[PDF][PDF] Dabigatran, Rivaroxaban, Apixaban, Argatroban und Fondaparinux und ihre Effekte auf Point-of-Care-sowie Plättchenfunktionstests
J Busse - 2020 - scholar.archive.org
Abstract Busse Jessica Dabigatran, Rivaroxaban, Apixaban, Argatroban und Fondaparinux
und ihre Effekte auf Point-of-Caresowie Plättchenfunktionstests Einleitung: Nachdem …
und ihre Effekte auf Point-of-Caresowie Plättchenfunktionstests Einleitung: Nachdem …
Effects of rivaroxaban and apixaban on intimal hyperplasia in rabbits
MB Kemahlı, T Gençpınar, H Dursun… - Turkish Journal of …, 2022 - openaccess.kavram.edu.tr
Aim: Intimal hyperplasia causes vascular occlusion and its optimal treatment is unknown. In
this study, we evaluated the effectiveness of Apixaban and Rivaroxaban treatment for …
this study, we evaluated the effectiveness of Apixaban and Rivaroxaban treatment for …
Anti-Faktor IIa-spezifische Point-of-Care Gerinnungstestung unter Behandlung mit Dabigatran und ihre Bedeutung für die klinische Schlaganfall-Akutversorgung
FJ Härtig - 2022 - tobias-lib.ub.uni-tuebingen.de
Einleitung: Trotz Behandlung mit direkten oralen Antikoagulanzien (DOAK) besteht bei
Patienten mit Vorhofflimmern ein jährliches Schlaganfallrisiko von 1-2%. Zusätzlich …
Patienten mit Vorhofflimmern ein jährliches Schlaganfallrisiko von 1-2%. Zusätzlich …
[PDF][PDF] The impact of direct oral anticoagulants on viscoelastic testing–A systematic
SD Sahli, C Castellucci, TR Roche, J Rössler… - 2022 - scholar.archive.org
Background: In case of bleeding patients and in acute care, the assessment of residual
direct oral anticoagulant (DOAC) activity is essential for evaluating the potential impact on …
direct oral anticoagulant (DOAC) activity is essential for evaluating the potential impact on …
[PDF][PDF] Цироз печінки та фібриляція передсердь: актуальні питання діагностики та лікування
V Chernyavsky, A Baylo - Family medicine, 2020 - family-medicine.com.ua
У статті також розглядаються особливості печінкового метаболізму та фармакокінетики
прямих оральних антикоагулянтів. Наводяться існуючі рекомендації з використання …
прямих оральних антикоагулянтів. Наводяться існуючі рекомендації з використання …
[HTML][HTML] Understanding the effects of NOAC combined with antiplatelet therapy on clot kinetics
DA Gorog - Thrombosis and haemostasis, 2020 - thieme-connect.com
The pharmacodynamic effects of oral anticoagulants (OACs) on the coagulation pathway
and the effect of antiplatelet therapy (APT) on platelet activation, used in isolation, have …
and the effect of antiplatelet therapy (APT) on platelet activation, used in isolation, have …
[PDF][PDF] Optimization of monitoring and management of anticoagulant therapy
JS Biedermann - Optimization of monitoring and management of …, 2017 - repub.eur.nl
Optimization of monitoring and management of anticoagulant therapy Optimization of
monitoring and management of anticoagulant therapy JOSEPH S. BIEDERMANN Page 2 Page …
monitoring and management of anticoagulant therapy JOSEPH S. BIEDERMANN Page 2 Page …
Clot structure and plasma microparticles in atrial fibrillation
C Voukalis - 2020 - etheses.bham.ac.uk
Chronic oral anticoagulation (OAC) is an important decision related with stroke
thromboprophylaxis in non-valvular atrial fibrillation (NVAF). Almost a decade after the …
thromboprophylaxis in non-valvular atrial fibrillation (NVAF). Almost a decade after the …
[PDF][PDF] Administering Thrombolysis for Acute Ischemic Stroke in Patients Taking Direct Oral Anticoagulants To Treat or How to Treat
J David, PD Seiffge, I Center, F Bern - 2021 - researchgate.net
Direct Oral Anticoagulants and Acute Ischemic Stroke Direct oral anticoagulants (DOAC), the
factor Xa inhibitors rivaroxaban, apixaban, edoxaban, and the direct thrombin inhibitor …
factor Xa inhibitors rivaroxaban, apixaban, edoxaban, and the direct thrombin inhibitor …